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Following the submission of application EFSA-GMO-RX-001 under Regulation (EC) No 1829/2003 from
Pioneer Overseas Corporation and Dow Agrosciences LLC, the Panel on Genetically Modiﬁed Organisms
of the European Food Safety Authority (GMO Panel) was asked to deliver a scientiﬁc risk assessment
on the data submitted in the frame of a renewal of authorisation application of the insect-resistant and
herbicide-tolerant genetically modiﬁed (GM) maize 1507. The data package received in the frame of
this renewal application contained post-market environmental monitoring reports, a systematic search
and evaluation of literature, an updated bioinformatics analysis and additional documents or studies
performed by or on behalf of the applicant. The GMO Panel assessed this data package for possible
new hazards, modiﬁed exposure or new scientiﬁc uncertainties identiﬁed during the authorisation
period and not previously assessed in the frame of the original application. Under the assumption that
the DNA sequence of the event in maize 1507 considered for renewal is identical to the corrected
sequence of the originally assessed event, the GMO Panel concludes that no new hazards or modiﬁed
exposure and no new scientiﬁc uncertainties were identiﬁed for the application for renewal that would
change the conclusions of the original risk assessment on maize 1507 (EFSA, 2005b, 2009).
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Summary
Following the submission of application EFSA-GMO-RX-001 under Regulation (EC) No 1829/20031
from Pioneer Overseas Corporation and Dow Agrosciences LLC, the Panel on Genetically Modiﬁed
Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientiﬁc opinion
on the data submitted in the frame of a renewal of authorisation application of the insect-resistant
and herbicide-tolerant genetically modiﬁed (GM) maize 1507. The scope of renewal application
EFSA-GMO-RX-001 is for food and feed uses, import and processing, but excludes cultivation within
the European Union (EU).
At the time of submission of the renewal application EFSA-GMO-RX-001, no EFSA Guidance
document was in place to assist the applicant in the preparation and presentation of their renewal
application. Therefore, the applicant submitted data in accordance with Articles 11 and 23 of
Regulation (EC) No 1829/2003. At the time EFSA validated renewal application EFSA-GMO-RX-001, the
‘Guidance for renewal applications of genetically modiﬁed food and feed authorised under Regulation
(EC) No 1829/2003’ (EFSA GMO Panel, 2015) was published and the GMO Panel requested the
applicant to update the data package to be in line with these guidelines.
In delivering its scientiﬁc opinion, the GMO Panel took into account application EFSA-GMO-RX-001,
additional information provided by the applicant, scientiﬁc comments submitted by the Member States
and relevant scientiﬁc publications. The data package received in the frame of the renewal application
EFSA-GMO-RX-001 contained: post-market environmental monitoring reports, systematic search and
evaluation of literature, updated bioinformatics analyses and additional documents or studies
performed by or on behalf of the applicant. The GMO Panel assessed this data package for possible
new hazards, modiﬁed exposure or new scientiﬁc uncertainties identiﬁed during the authorisation
period and not previously assessed in the frame of the original application.
In conclusion, under the assumption that the DNA sequence of the event in maize 1507 considered
for renewal is identical to the corrected sequence of the originally assessed event, the GMO
Panel concludes that no new hazards or modiﬁed exposure and no new scientiﬁc uncertainties were
identiﬁed for the application for renewal that would change the conclusions of the original risk
assessment on maize 1507 (EFSA, 2005b, 2009).
1 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modiﬁed
food and feed. OJ L 268, 18.10.2003, p. 1–23.
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1 Introduction
1.1. Background
On 18 May 2015, the European Food Safety Authority (EFSA) received from the European
Commission (DG SANTE) application EFSA-GMO-RX-001 for the renewal of authorisation of genetically
modiﬁed (GM) maize 1507 for food and feed uses, import and processing submitted by Pioneer Overseas
Corporation and Dow AgroSciences LLC within the framework of Regulation (EC) No 1829/2003. Before
sending the application to EFSA, the European Commission (DG SANTE) checked whether the data
submitted in the frame of this renewal application were in line with the legal requirements laid down in
Articles 11 and 23 of Regulation (EC) No 1829/2003.
After receiving the application EFSA-GMO-RX-001, and in accordance with Articles 5(2)(b) and 17(2)
(b) of Regulation (EC) No 1829/2003, EFSA informed Member States and made the summary of the
application available to the public on the EFSA website.2
On 3 July 2015, EFSA declared the application valid in accordance with Articles 6(1) and 18(1) of
Regulation (EC) No 1829/2003. EFSA made the valid application available to Member States and the
European Commission, and consulted nominated risk assessment bodies of Member States, including
national Competent Authorities within the meaning of Directive 2001/18/EC following the requirements
of Articles 6(4) and 18(4) of Regulation (EC) No 1829/2003, to request their scientiﬁc opinion. Member
States had 3 months after the opening of the Member State commenting period (until 7 October 2015)
to make their opinion known.
Following the submission of notiﬁcations and applications C/NL/00/10, C/ES/01/01, EFSA-GMO-NL-
2004-02 and EFSA-GMO-RX-1507 and the publication of EFSA scientiﬁc opinions (EFSA 2004, 2005a,b,
2009), the placing on the market of maize 1507 for food/feed uses, except cultivation, was authorised
by Commission Decisions 2005/772/EC3, 2006/197/EC4, DGM SAS C/NL/00/10 and 2011/365/EU5.
A copy of these authorisations was provided by the applicant.6
On 21 September 2015, 19 October 2015, 18 March 2016, 12 February 2016, 11 March 2016,
18 March 2016, 11 July 2016 and on 10 October 2016, EFSA received additional information (requested
on 10 July 2015, 21 July 2015, 11 December 2015, 18 December 2015, 11 January 2016, 25 April 2016
and 13 May 2016, respectively). The applicant also spontaneously submitted additional information on
19 November 2015 and 25 November 2015.
In giving its scientiﬁc opinion to the European Commission, the Member States and the applicant,
and in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003, EFSA has
endeavoured to respect a time limit of 6 months from the acknowledgement of the valid application.
As additional information was requested by the GMO Panel, the time limit of 6 months was extended
accordingly, in line with Articles 6(1), 6(2), 18(1) and 18(2) of Regulation (EC) No 1829/2003.
According to Regulation (EC) No 1829/2003, this scientiﬁc opinion is to be seen as the report
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA overall
opinion in accordance with Articles 6(5) and 18(5).
1.2. Terms of Reference as provided by the requestor
The GMO Panel was requested to carry out a scientiﬁc risk assessment on the data submitted in the
frame of a renewal of authorisation application for maize 1507 for food and feed uses, import and
processing in accordance with Articles 11 and 23 of Regulation (EC) No 1829/2003.
Where applicable, any conditions or restrictions which should be imposed on the placing on the
market and/or speciﬁc conditions or restrictions for use and handling, including post-market monitoring
requirements based on the outcome of the risk assessment and, in the case of GMOs or food/feed
containing or consisting of GMOs, conditions for the protection of particular ecosystems/environment
2 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2015-00342
3 Commission Decision of 3 November 2005 concerning the placing on the market, in accordance with Directive 2001/18/EC of
the European Parliament and of the Council, of a maize product (Zea mays L., line 1507) genetically modiﬁed for resistance to
certain lepidopteran pests and for tolerance to the herbicide glufosinate-ammonium. OJ L 291, 5.11.2005, p. 42–44.
4 Commission Decision of 3 March 2006 authorising the placing on the market of food containing, consisting of, or produced
from genetically modiﬁed maize line 1507 (DAS-Ø15Ø7-1) pursuant to Regulation (EC) No 1829/2003 of the European
Parliament and of the Council. OJ L 70, 9.3.2006, p. 82–86.
5 Commission Decision of 17 June 2011 amending Decision 2006/197/EC as regards the renewal of the authorisation to place on
the market existing feed produced from genetically modiﬁed maize line 1507 (DAS-Ø15Ø7-1) pursuant to Regulation (EC)
No 1829/2003 of the European Parliament and of the Council. OJ L 163, 23.6.2011, p. 52–54.
6 Dossier: Part II – Section 1.
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and/or geographical areas should be indicated in accordance with Articles 6(5)(e) and 18(5)(e) of
Regulation (EC) No 1829/2003.
The GMO Panel was not requested to give an opinion on information required under Annex II to
the Cartagena Protocol. Furthermore, the GMO Panel did not consider proposals for labelling and
methods of detection (including sampling and the identiﬁcation of the speciﬁc transformation event in
the food/feed and/or food/feed produced from it), which are matters related to risk management.
2. Data and methodology
2.1. Data
The data for application EFSA-GMO-RX-001 submitted by the applicant at the time of submission,
spontaneously submitted or in reply to requests for additional information are speciﬁed below. In the
frame of this renewal application, no new sequencing study was submitted among the additional
documents or studies performed by or on behalf of the applicant. However, the applicant clariﬁed
that the maize 1507 sequence information submitted in the original application (EFSA-GMO-NL-2004-02,
C/ES/01/01, C/NL/00/10) was subsequently corrected for sequencing errors affecting four single
nucleotides.7
According to the EFSA guidelines for renewal applications of genetically modiﬁed food and feed
authorised under Regulation (EC) No 1829/2003 (EFSA GMO Panel, 2015), the GMO Panel evaluated
the data provided in the frame of this maize 1507 renewal application under the assumption that the
event sequence is identical to the corrected sequence of the originally assessed event.
2.1.1. Post-market monitoring reports8
Based on the outcome of the initial food and feed risk assessment, a post-market monitoring plan
for monitoring of GM food/feed was not required by the authorising decisions. The implementation of
a post-market environmental monitoring (PMEM) plan, consisting of a general surveillance plan to
check for any adverse effects on the environment or human health arising from handling maize 1507,
was a condition for the authorisation. As no potential adverse environmental effects were identiﬁed in
the environmental risk assessment (ERA) of maize 1507 (EFSA, 2004, 2005a,b, 2009), case-speciﬁc
monitoring was not considered necessary by the GMO Panel.
The applicant provided nine annual PMEM reports covering a reporting period from 16 March 2006
till June 2014. The annual PMEM plans submitted by the applicant included (1) the description of a
centralised system established by EuropaBio for the collection of information recorded by various
operators (federations involved in maize (or bulk grain) import and processing) to report any observed
adverse effect(s) of the GMO on the environment or human health arising from handling of
maize 1507; (2) the reports of the surveillance activities conducted by such operators; and (3) the
review of relevant scientiﬁc peer-reviewed publications retrieved from literature searches.
The applicant provided an overall assessment of the annual PMEM reports in the renewal dossier. The
GMO Panel requested on 10 July 2015 further information on the implementation of the annual PMEM
and general surveillance plan, for which a response was provided by the applicant on 19 October 2015.
2.1.2. Systematic search and evaluation of literature9
In addition to the literature searches submitted within the annual PMEM reports, the applicant
conducted two additional literature searches, covering a part of the authorisation period from 2009 till
2015. To be in line with the guidelines for renewal applications (EFSA GMO Panel, 2015), the GMO
Panel requested the applicant on 10 July 2015 to submit a systematic literature search covering the
complete duration of the event’s authorisation (from 2006 till 2015) and following the principles
outlined in the EFSA guidance on the application of systematic review methodology for food and feed
safety assessment (EFSA, 2010). The applicant responded to that request on 19 October 2015. Further
clariﬁcations on the eligibility criteria used by the applicant for inclusion or exclusion of relevant
publications after the initial systematic literature search were requested by the GMO Panel on 11
January 2016. The applicant responded to this request on 11 March 2016. The outcome of the
literature search is presented in Section 3.2.
7 Additional information 10/10/2016
8 Dossier: Part II – Section 2 and additional information: 19/10/2015.
9 Dossier: Part II – Section 3.2.3 and additional information: 19/10/2015, 11/3/2016.
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2.1.3. Updated bioinformatics10
At the time of submission of the renewal dossier, the applicant provided a bioinformatics package
for maize 1507, including data on the insert sequences and sequences ﬂanking the inserts and an
analysis of all possible open reading frames (ORFs) within the insert and spanning the junction sites,
deﬁned from stop to stop, and newly expressed proteins for potential identity to allergens or toxins.
This bioinformatics package was based on the original sequence corrected for four sequencing errors.7
The applicant spontaneously submitted a new updated bioinformatics package, including an analysis of
possible horizontal gene transfer (HGT), on 21 September 2015. This bioinformatics package, however,
was based on the original sequence corrected for only one of the four sequencing errors. Therefore,
the applicant spontaneously submitted another updated bioinformatics package based on the original
sequence corrected for the four sequencing errors, and included an analysis of all possible ORFs within
the insert and spanning the junction sites for potential identity to allergens or toxins and a new HGT
analysis (19 November 2015). This package also included an analysis of newly expressed proteins for
similarity to toxins. EFSA requested further analysis of the potential for expression of the putative
ORFs that showed 35% or more identity with possible allergens. The applicant provided these data on
18 March 2016. On 25 April 2016, the GMO Panel requested further clariﬁcation on the exact
sequences used in the different bioinformatics packages. The applicant provided the requested
clariﬁcation on 10 October 2016. Therefore, all elements of the bioinformatics analyses were
performed on the original sequence corrected for four sequencing errors.
2.1.4. Additional documents or studies provided by the applicant11
In line with the renewal guidance requirements (EFSA GMO Panel, 2015), the applicant provided an
overview on the worldwide approvals of maize 1507. The GMO Panel requested the applicant on 10
July 2015 (1) to list and provide the summary of all unpublished studies produced, controlled or
sponsored by the applicant or provided to the applicant by a third party, performed over the course of
the authorisation period and not previously submitted to the EU, and (2) to assess their relevance for
molecular characterisation, human and animal safety and the environment. On 19 October 2015, the
applicant submitted a list with 10 study titles and a summary for three of them, and evaluated the
relevance for molecular characterisation, food and feed safety and the environment (Table 1).
Based on the information provided, the GMO Panel requested from the applicant on 11 December
2015 the summary of the PHI-2014-178 study and the full study reports of the six food and feed
related studies listed and considered potentially relevant for the assessment. The applicant submitted
the requested information on 12 February 2016 and spontaneously sent the full study report of the
PHI-2014-178 study.
Table 1: List of additional studies performed by Pioneer Overseas Corporation or Dow Agrosciences
LLC over the course of the authorisation period (2006–2015) with regard to the evaluation
of the safety of the food/feed and the risks of the food/feed to humans, animal or the
environment from maize 1507
Study identiﬁcation Title
PHI-2011-139(a) Event conﬁrmation by polymerase chain reaction analysis of DAS-Ø15Ø7-1 maize seed
PHI-2008-100(a) Expressed trait protein concentration of maize lines containing event DAS-Ø15Ø7-1:
Johnston, IA
PHI-2009-102(a) Sequencing characterization of plasmid PHP8999
PHI-2014-178(a) Sequence characterization of insert and ﬂanking genomic regions of DAS-Ø15Ø7-1 maize
PHI-2007-177(a) Field production of maize grain containing event DAS-Ø15Ø7-1: Chile location
PHI-2010-204(a) Field production and characterization of grain from a maize line containing the event
DAS-01507-1: Chile test site
PHI-2013-291(a) Nutrient compositional and contaminant analyses of maize grain from lots R10CN204-CH-
6091 and R10CN-204-CH-5001
121156(b) PAT: Acute oral toxicity study in Crl:CD1(ICR) mice. 2013
120937(b) Effect of heat treatment on phosphinothricin acetyltransferase (PAT) protein
10 Dossier: Part II – Section 3.2.2 and additional information: 21/9/2015, 19/11/2015, 18/3/2016, 10/10/2016.
11 Dossier: Part II – Sections 2.3.1.1, Section 3.1 and additional information: 19/10/2015, 12/2/2016.
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2.1.5. Overall assessment as provided by the applicant12
In line with the requirements listed in the renewal guidance (EFSA GMO Panel, 2015), the GMO
Panel requested the applicant on 10 July 2015 to submit an evaluation on whether the collected
information leads to the identiﬁcation of new hazards or modiﬁed exposure, or adds new scientiﬁc
uncertainties. The applicant provided its assessment on 19 October 2015. All the additional information
received after 19 October 2015 also included an assessment by the applicant for the identiﬁcation of
new hazards or modiﬁed exposure, or new scientiﬁc uncertainties.
2.1.6. Monitoring plan and proposal for improving the conditions of the original
authorisation13
The applicant indicated in the dossier that the environmental monitoring plan was appropriate and
does not need any changes to the conditions of release and use as laid down in the initial
authorisation.
2.2. Methodologies
The GMO Panel carried out a scientiﬁc risk assessment on the data submitted in the frame of a
renewal of authorisation application for maize 1507 for food and feed uses, import and processing in
accordance with Articles 11 and 23 of Regulation (EC) No 1829/2003. The GMO Panel took into
account the requirements described in its guideline for the risk assessment of renewal applications of
GM food and feed authorised under Regulation (EC) No 1829/2003 (EFSA GMO Panel, 2015).
The comments raised by Member States are addressed in Annex G of EFSA’s overall opinion14 and
were taken into consideration during the scientiﬁc risk assessment.
3. Assessment
3.1. Evaluation of the post-market environmental monitoring reports
In the general surveillance activities covering the authorisation period of maize 1507, no adverse
effects were reported by the applicant.
3.2. Evaluation of the systematic search and evaluation of literature
The applicant performed a systematic literature search to identify scientiﬁc publications related to
maize 1507 covering the authorisation period between 2006 and 2015. The applicant used Scopus and
CAB Direct as scientiﬁc literature databases. The search strings were adapted for each database. The
search terms used for the literature search included synonyms, scientiﬁc and common names, brand
and generic names and British and US variants (e.g. maize and corn). Boolean operators (i.e. OR,
AND) were used to combine terms, while wild card symbols allowed to retrieve spelling variants. No
restrictions (e.g. language, publication type) were applied with the exception of the time period.
Altogether 974 unique entries were identiﬁed which were manually screened for their relevance for
the molecular characterisation, food and feed safety assessment and environmental safety assessment
of maize 1507.
After a screen based on title, abstract or full text, the applicant identiﬁed 13 original scientiﬁc
publications relevant for the risk assessment of maize 1507. Eleven publications related to the food
and feed safety assessment, while two publications related to the ERA of maize 1507. Eleven of the 13
selected original scientiﬁc publications had been previously assessed by the GMO Panel (EFSA, 2009;
EFSA GMO Panel, 2011, 2012) and it had been concluded that none of them raised concerns or new
information that could change the conclusions of the original risk assessment. The GMO
Study identiﬁcation Title
131205(b) Inﬂuences of pH on phosphinothricin acetyltransferase (PAT) protein
(a): Performed by Pioneer Hi-Bred International, Inc.
(b): Performed by Dow Agrosciences LLC.
12 Additional information: 19/10/2015.
13 Dossier: Part II – Section 2.5.
14 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2016-00817
Scientiﬁc opinion on a renewal application for maize 1507
www.efsa.europa.eu/efsajournal 8 EFSA Journal 2017;15(1):4659
Panel assessed the two remaining original scientiﬁc publications, Jemison and Reberg-Horton (2010)
and Bowers et al. (2014), and considered that neither of them raised any new concerns for human
and animal health and the environment which could change the original risk assessment conclusion on
maize 1507.
3.3. Evaluation of the updated bioinformatics
The latest received updated bioinformatic analyses of the junction regions for the events in
maize 1507 conﬁrmed that no known endogenous genes were disrupted by any of the inserts.
Updated bioinformatic analyses of the amino acid sequence of the newly expressed Cry1F and PAT
proteins revealed no signiﬁcant similarities to toxins and allergens. In addition, updated bioinformatics
analyses of the newly created ORFs within the inserts and at their junctions indicate that the
expression of an ORF showing signiﬁcant similarities to toxins or allergens is highly unlikely.
In order to assess the possibility for HGT by homologous recombination (HR), the applicant
performed a sequence identity analysis of the regions of bacterial origin in maize 1507. No elements
with sufﬁcient length and identity to support HR were identiﬁed (EFSA, 2015). There is no information
that would change the previous conclusion of the GMO Panel that the unlikely, but theoretically
possible, horizontal transfer of recombinant genes from maize 1507 to bacteria does not raise any
environmental safety concern.
3.4. Evaluation of the additional documents or studies provided by the
applicant
The GMO Panel has evaluated the summary and/or the full study reports of the relevant studies
provided and this new information did not raise any concern for human and animal health, and the
environment which would change the original risk assessment conclusion on maize 1507.
3.5. Evaluation of the overall assessment as provided by the applicant
The GMO Panel assessed the information provided by the applicant and did not identify new
hazards, relevant changes in the exposure to products containing maize 1507 or new scientiﬁc
uncertainties which would change the original risk assessment conclusions of maize 1507.
3.6. Evaluation of the monitoring plan and proposal for improving the
conditions of the original authorisation
The GMO Panel is of the opinion that the PMEM plan and the general surveillance system
implemented by the applicant is in line with the principles and objectives outlined in Annex VII of
Directive 2001/18/EC and Decision 2002/811/EC establishing guidance notes supplementing Annex VII
to Directive 2001/18/EC.
4. Conclusions
Under the assumption that the DNA sequence of the event in maize 1507 considered for renewal is
identical to the corrected sequence of the originally assessed event, the GMO Panel concludes that no
new hazards or modiﬁed exposure and no new scientiﬁc uncertainties were identiﬁed for the
application for renewal that would change the conclusions of the original risk assessment on
maize 1507 (EFSA, 2005b, 2009).
Documentation provided to EFSA
1) Letter from the European Commission received on 18 May 2015 for the continued
marketing of genetically modiﬁed maize 1507 in accordance with Articles 11 and 23 of
Regulation (EC) No 1829/2003 by Pioneer Overseas Corporation and Dow AgroSciences Ltd.
(EFSA-GMO-RX-001).
2) Acknowledgement letter dated 27 May 2015 from EFSA to European Commission.
3) Letter from EFSA to applicant dated 3 July 2015 delivering the ‘Statement of Validity’ for
application regarding genetically modiﬁed maize 1507 (EFSA-GMO-RX-001) submitted by
Pioneer Overseas Corporation and Dow AgroSciences Ltd. under Regulation (EC) No 1829/2003.
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4) Letter from EFSA to applicant dated 10 July 2015 requesting additional information and
stopping the clock.
5) Letter from EFSA to applicant 21 July 2015 requesting additional information and
maintaining the clock stopped.
6) Letter from applicant to EFSA received on 21 September 2015 providing additional
information.
7) Letter from applicant to EFSA received on 19 October 2015 providing additional information.
8) Letter from applicant to EFSA received on 19 November 2015 providing additional
information spontaneously.
9) Letter from EFSA to applicant 11 December 2015 requesting additional information and
maintaining the clock stopped.
10) Letter from EFSA to applicant 18 December 2015 requesting additional information and
maintaining the clock stopped.
11) Letter from EFSA to applicant 11 January 2016 requesting additional information and
maintaining the clock stopped.
12) Letter from applicant to EFSA received on 12 February 2016 providing additional
information.
13) Letter from applicant to EFSA received on 11 March 2016 providing additional information.
14) Letter from applicant to EFSA received on 18 March 2016 providing additional information.
15) Email from EFSA to applicant dated 21 March 2016 re-starting the clock from 18 March
2016.
16) Letter from EFSA to applicant dated 25 April 2016 requesting additional information and
stopping the clock.
17) Letter from EFSA to applicant 13 May 2016 requesting additional information and
maintaining the clock stopped.
18) Letter from applicant to EFSA dated 8 June 2016 asking for an extension of the deadline to
submit information.
19) Letter from EFSA to applicant dated 16 June asking for clariﬁcation of the extension of
deadline requested on 8 June 2106.
20) Letter from applicant to EFSA received on 5 July 2016 providing a timeline for submission of
responses.
21) Letter from applicant to EFSA received on 11 July 2016 providing additional information.
22) Letter from applicant to EFSA received on 30 August 2016 providing a timeline for
submission of responses.
23) Letter from applicant to EFSA received on 10 October 2016 providing additional
information.
24) Email from EFSA to applicant dated 11 October 2016 re-starting the clock from 10 October
2016.
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HGT horizontal gene transfer
HR homologous recombination
ORFs open reading frames
PAT phosphinothricin acetyltransferase
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